Redox signaling in sickle cell disease
- 2 May 2019
- journal article
- review article
- Published by Elsevier in Current Opinion in Physiology
- Vol. 9, 26-33
Abstract
No abstract availableKeywords
Funding Information
- Vascular Medicine Institute, University of Pittsburgh
- National Institutes of Health (HL128371)
- National Institutes of Health (NS070711)
- National Institutes of Health (T32 HD071834)
- Hemophilia Center of Western Pennsylvania
- Institute For Transfusion Medicine
- Medical Center, University of Pittsburgh
This publication has 47 references indexed in Scilit:
- Oxidative stress in β-thalassaemia and sickle cell diseaseRedox Biology, 2015
- Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell diseaseBlood, 2015
- Vasculopathy and pulmonary hypertension in sickle cell diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammationBlood, 2014
- Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a reviewFrontiers of Medicine, 2014
- Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activationBlood, 2014
- Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell diseaseBlood, 2014
- Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease miceJournal of Lipid Research, 2013
- Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell diseaseBlood, 2012
- Identification of Hemopexin as an Anti-Inflammatory Factor That Inhibits Synergy of Hemoglobin with HMGB1 in Sterile and Infectious InflammationThe Journal of Immunology, 2012